JNCCN study reveals neuroendocrine tumor mortality patterns to inform treatment decisions

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A study published in JNCCN—Journal of the National  Comprehensive Cancer Network demonstrated that among all patients with neuroendocrine tumors, the risk of dying of  cancer was higher than that of dying of other causes—but mortality varies by primary tumor site. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents